Is UCCPF or MRK a better dividend investment in 2026?

UCCPF currently yields 400000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: UCCPF offers higher current income.

What is the dividend yield difference between UCCPF and MRK?

UCCPF has a forward dividend yield of 400000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 399997.24 percentage points.

Home › Compare › UCCPF vs MRK

UCCPF vs MRK: Dividend Comparison 2026

UCCPF yields 400000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 UCCPF wins by $5.011119029548644e+32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

UCCPF

● Live price

400000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.011119029548644e+32M

Annual income

$500,865,583,351,836,840,000,000,000,000,000,000,000.00

Full UCCPF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — UCCPF vs MRK

📍 UCCPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	UCCPF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, UCCPF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

UCCPF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UCCPF

Annual income on $10K today (after 15% tax)

$34,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, UCCPF beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UCCPF + MRK for your $10,000?

UCCPF: 50%MRK: 50%

100% MRK50/50100% UCCPF

Portfolio after 10yr

$2.505559514774322e+32M

Annual income

$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr

Blended yield

99.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UCCPF

No analyst data

Altman Z

-10.5

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UCCPF buys

MRK buys

No recent congressional trades found for UCCPF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUCCPFMRK

Forward yield	400000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$5.011119029548644e+32M	$56.8K ✓
Annual income after 10y	$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$5.010957816668433e+32M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: UCCPF vs MRK ($10,000, DRIP)

Year	UCCPF Portfolio	UCCPF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$40,010,700	$40,000,000.00	$11,206	$366.19	+$40.00M → UCCPF
2	$149,615,521,729	$149,572,710,280.37	$12,650	$502.35	+$149615.51M → UCCPF
3	$522,880,052,725,200	$522,719,964,116,949.25	$14,407	$694.19	+$522880052.71M → UCCPF
4	$1,707,862,989,289,045,000	$1,707,303,507,632,628,700.00	$16,585	$967.82	+$1707862989289.03M → UCCPF
5	$5,213,509,402,845,684,000,000	$5,211,681,989,447,144,000,000.00	$19,342	$1,363.89	+$5213509402845684.00M → UCCPF
6	$14,874,219,058,409,543,000,000,000	$14,868,640,603,348,497,000,000,000.00	$22,913	$1,947.19	+$14874219058409543680.00M → UCCPF
7	$39,661,196,234,050,755,000,000,000,000	$39,645,280,819,658,260,000,000,000,000.00	$27,662	$2,823.89	+$3.966119623405075e+22M → UCCPF
8	$98,838,436,350,327,300,000,000,000,000,000	$98,795,998,870,356,880,000,000,000,000,000.00	$34,159	$4,173.35	+$9.88384363503273e+25M → UCCPF
9	$230,205,236,474,344,900,000,000,000,000,000,000	$230,099,479,347,450,050,000,000,000,000,000,000.00	$43,337	$6,308.80	+$2.302052364743449e+29M → UCCPF
10	$501,111,902,954,864,400,000,000,000,000,000,000,000	$500,865,583,351,836,840,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$5.011119029548644e+32M → UCCPF

UCCPF vs MRK: Complete Analysis 2026

UCCPF — Stock

Adamant Holdings Inc. operates as a telecom carrier worldwide. The company is involved in the international voice over IP (VoIP) wholesale business with a focus on wholesale international long-distance traffic termination. It also offers UpcoPay, that enables the transfer of money between Upco users and vendors; and VoIP smartphone application, which allows customers to send and receive local and international long-distance calls through an internet connection. In addition, the company provides digital services. The company was formerly known as Upco International Inc. and changed its name to Adamant Holdings Inc. in May 2022. Adamant Holdings Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Full UCCPF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this UCCPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UCCPF vs SCHD UCCPF vs JEPI UCCPF vs O UCCPF vs KO UCCPF vs MAIN UCCPF vs JNJ UCCPF vs ABBV UCCPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.